International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.
暂无分享,去创建一个
Hans-Peter Sinn | Anthony Howell | Wolfgang Eiermann | A. Howell | V. Valero | W. Eiermann | R. Souchon | H. Senn | M. Untch | Roy E. Smith | J. Blohmer | G. von Minckwitz | L. Gianni | S. Costa | H. Sinn | M. Kaufmann | P. Beuzeboc | Vicente Valero | Luca Gianni | Gunter von Minckwitz | Michael Untch | Serban Dan Costa | Jens-Uwe Blohmer | Manfred Kaufmann | Hans-Jörg Senn | Roy Smith | Philippe Beuzeboc | Tanja Volm | Rainer Souchon | Rolf Sittek | Augustinos H Tulusan | T. Volm | A. Tulusan | Rolf Sittek
[1] P. Hurteloup,et al. Inflammatory Breast Cancer: Pilot Study of Intensive Induction Chemotherapy (FEC‐HD) Results in a High Histologic Response Rate , 1993 .
[2] B Fisher,et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. , 1989, The New England journal of medicine.
[3] Christine Solbach,et al. Identification of high risk breast-cancer patients by gene expression profiling , 2002, The Lancet.
[4] M. Kaufmann,et al. Histologische Regression des Mammakarzinoms nach primärer (neoadjuvanter) Chemotherapie , 1994 .
[5] J. Blohmer,et al. Primary endpoint analysis of the GEPARDUO study: Comparing dose-dense with sequential adriamycin/docetaxel combination as preoperative chemotherapy (PCHT) in operable breast cancer (T2-3, N0-2, M0) , 2003 .
[6] C. V. D. van de Velde,et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] L Simpson-Herren,et al. Effects of surgery on the cell kinetics of residual tumor. , 1976, Cancer treatment reports.
[8] R. Collins,et al. Ovarian ablation in early breast cancer: overview of the randomised trials , 1996, The Lancet.
[9] B Fisher,et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. , 1985, The New England journal of medicine.
[10] C. Jacquillat,et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast‐conserving treatment of 250 patients with all stages of infiltrative breast cancer , 1990, Cancer.
[11] B. Gusterson,et al. High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] D. Wickerham,et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[14] G. Hortobagyi,et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] G. Hortobagyi,et al. Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Dixon,et al. The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] G. Calais,et al. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm , 1994, Cancer.
[18] Fiona J Gilbert,et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] X. Sastre,et al. Pathological response to neoadjuvant chemotherapy Final results of a prospective randomized trial of 4AT vs 4AC as induction therapy in patients with operable breast cancer using Sataloff classification , 1999 .
[20] D. L. Berry,et al. Management of breast cancer during pregnancy using a standardized protocol. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Anna L. Brown,et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] M. Baum,et al. Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. , 1993, European journal of cancer.
[23] Mike Clarke,et al. Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[24] M. Kaufmann,et al. [Current state of chemosensitivity testing of tumors]. , 2008, Deutsche medizinische Wochenschrift.
[25] B. Asselain,et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. , 1994, European journal of cancer.
[26] G. Bonadonna,et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] S Charrier,et al. Clinical and pathological response to primary chemotherapy in operable breast cancer. , 1997, European journal of cancer.
[28] A. Luini,et al. Pre-operative chemotherapy and radiotherapy in breast cancer. , 1998, European journal of cancer.
[29] A. Vincent-Salomon,et al. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Donald L Weaver,et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] E. Mallon,et al. Optimum number of core biopsies for accurate assessment of histological grade in breast cancer , 2002, The British journal of surgery.
[32] N. Mantel,et al. The effect of removal of a "primary" tumor on the development of spontaneous metastases. I. Development of a standardized experimental technic. , 1959, Cancer research.
[33] J. Vermorken. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000, The Lancet.
[34] U. Chetty,et al. A HUMAN TUMOUR MODEL , 1986, The Lancet.
[35] A. Luini,et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. , 1990, Journal of the National Cancer Institute.
[36] G. Palazzoni,et al. Preoperative radiotherapy in the conservative treatment for breast cancer. , 1997, Rays.
[37] N Gunduz,et al. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. , 1983, Cancer research.
[38] U. Chetty,et al. Primary systemic therapy for operable breast cancer. , 1991, British Journal of Cancer.
[39] W. Eiermann,et al. Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] Z. Baloch,et al. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. , 1995, Journal of the American College of Surgeons.
[41] R. Gelber,et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] A. Vincent-Salomon,et al. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer , 2000, British Journal of Cancer.
[43] S. Edge,et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] J. Bryant,et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. , 2001, Journal of the National Cancer Institute. Monographs.
[45] N Gunduz,et al. Effect of surgical removal on the growth and kinetics of residual tumor. , 1979, Cancer research.
[46] M. Ellis,et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.